$YGYI Rings Nasdaq Closing Bell as 2020 Wellness Week Company

$TGODF Restructures Executive Leadership Team

$SRAX BIGtoken Platform Empowers Consumers with Growing Data Privacy Concerns

• Recent poll shows consumers’ increasing distrust towards companies that collect personal data
• As concerns over data privacy grow, SRAX’s BIGtoken platform becomes more relevant
• In addition to protecting personal data, BIGtoken gives users a chance to earn money for providing consumer data

Consumer data is emerging as individuals’ “most ignored and valuable asset,” yet emerging privacy concerns give consumers legitimate pause when it comes to reaping data’s benefits (http://nnw.fm/X61Sp). SRAX Inc. (NASDAQ: SRAX) is on the forefront of these industry trends due to its diligence in protecting consumers while simultaneously empowering them to benefit from their data. While offering consumers unique technology and tools to safely approve and monetize their personal data, access is then sold to marketers that benefit from accurate consumer information and opinions. SRAX accomplishes all of this through its patented BIGtoken platform, which provides compensation to users who provide consumer data.

The Pew Research Center recently conducted a study regarding people’s feelings towards data privacy. The poll showed that consumers distrust the ways in which companies handle user data now more than ever. An estimated 80% of polled adults said that they were at least somewhat concerned with…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$PBIO Advantages of PCT Platform, Second Straight Year of Strong Publication Numbers

$LXRP Holds Key Position as Edible Cannabis Market Opens Wide

• Canada’s first nationally legal cannabis-infused edible products began hitting store shelves December 17, vastly broadening the market for products using the plant’s extracts
• Lexaria Bioscience has dedicated years of research to the development of its proprietary DehydraTECH technology, designed to enhance the effectiveness of orally consumed drug products such as cannabis as well as nicotine
• Testing of Lexaria’s 2.0 version of its DehydraTECH technology shows enormous improvement in the speed of payload delivery to the bloodstream, as well as the potential for delivering drugs across the body’s largely impenetrable blood-brain barrier to the central nervous system

Canada’s regulatory innovations in making cannabis products accessible nationwide for both therapeutic and recreational purposes have led to this year’s ‘Cannabis 2.0’ national rollout of laws for a new edible cannabis-infused market. Cannabis edibles, extracts and topicals became legal in October pending a 60-90-day regulatory approval process for product applications, and that timeline resulted in the first legal edibles becoming available December 16 (http://cnw.fm/eM5CQ), just in time for Christmas, subject to retailers’ delivery schedules.

Oral drug product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is well situated to take advantage of the market arising from Canada’s sweeping legal changes, as well as the burgeoning market for infused edibles in select states within the United States. Lexaria’s own ‘2.0’ version of its patented DehydraTECH™ oral drug delivery technology has shown an ability in lab animal testing to…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$SGLB Recognized for Creating Most Innovative Quality-Assurance Software for 3D Printing Industry

$GGBXF CMO to Participate in Panel Discussion at Upcoming Retail Industry Event

$CNPOF $RIV $RIV.V 2020 Annual Asia Hemp Summit Speakers Revealed

$BHAT Launches AR Child Abuse Prevention Course in 25 Preschools

$LXRP Patented DehydraTECH™ Platform Increases CBD Tissue Absorption by 1,937%

• DehydraTECH™ drug delivery platform achieved a 319% higher CBD blood concentration level at 60 minutes than the generic coconut oil formulation
• The technology can be used on the nicotine market, the pharmaceutical market, and the cannabinoid market
• No other company in the world has a patent for improved delivery of all non-psychoactive cannabinoids
• Partnership with one of the world’s largest tobacco companies with up to $12 million in Lexaria funding for clinical investigations and product development

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has launched a revolutionary technology that accelerates intestinal absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sweeteners or sugars, and other unhealthy practices. It is applicable to absorption of cannabis and nicotine, among other bioactive substances.

According to company data, DehydraTECH™ can be used successfully in multiple industries, including the nicotine market (estimated at approximately $746 billion), the pharmaceutical market (more than $68 billion), as well as the cannabinoid market…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$SGLB to Help Aerospace Manufacturers Overcome 3D Quality Manufacturing Problems

January 8, 2020

$CNPOF $RIV.V $RIV Approval to Apply Proprietary UV Tech to Medical Cannabis

$LXRP Kansas Governor Expresses Her Support for Marijuana Legalization

January 7, 2020

On Thursday, the Governor of Kansas, Laura Kelly, said that if the state lawmakers sent a bill seeking to legalize marijuana to her desk, there is a possibility that she would sign it into law.

Speaking about the legislative priorities for 2020 in several interviews, Gov. Kelly said that the lawmakers should legalize medical marijuana as it would help Kansas families whose children are suffering from serious ailments. Medical marijuana would also help in fighting the opioid crisis by reducing the use of prescription pain medication.

Although Gov. Kelly said that she is not in favor of legalizing adult-use marijuana, she also noted that if the legislation were to advance in the state, she would enact it.

Speaking to WIBW, Kelly said that she has not made a decision on what she would do, but her decision would rely on the wants of her people; if the residents of Kansas want it, and the legislature approves it, then she would most likely sign it.

The governor further stressed that her agenda for the 2020 legislative sessions is the legalization of marijuana for medical purposes.

Kelly further said that she wants medical marijuana to be well regulated and controlled so that it does not become the gateway for the legalization of marijuana. She also said that her wish is for medical marijuana to be viewed as a pharmaceutical and controlled product.

She added and said that medical marijuana should be legalized and because of its medicinal potential, families with kids suffering from Dravet syndrome could use it. Children with Dravet syndrome experience severe and frequent epileptic seizures, which could be managed using medical cannabis.

Gov. Kelly has been outspoken about her support for medical marijuana, as it was also part of her 2018 election campaign; however, it is essential to note that she is not at all enthusiastic about recreational marijuana legalization. Kelly said that she does not think the state of Kansas is ready for adult-use marijuana, but a recent survey shows that the majority of Kansas residents are in favor of the marijuana reform.

The survey, which was released in December 2019, showed that 63 percent of the state’s residents are in support of recreational marijuana legalization. This indicates that the task remains on the legislature to approve the legislation and forward it to the Governor’s desk.

The likelihood of legalizing medical marijuana in Kansas is looking up. Last year, a special legislative commission issued recommendations in support of developing a limited medical cannabis program. The program would give patients a chance to access medical marijuana products that are neither smoked nor vaped. The commission also recommended providing patients visiting from out of state with some form of legal protection.

In an interview with KSNT, Gov. Kelly said that she is aware that people have a desire for medical marijuana legalization and that she fully supports it and hopes that the legislature would approve it.

The marijuana industry, including Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and SinglePoint Inc. (OTCQB: SING), is most likely glad that things are looking up for the future of the industry in Kansas.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

$GGBXF Leverages Retail, Operations Expertise to Capitalize on Holiday Shopping

$TGODF Ohio Quickly Transitions into a Hemp Trendsetter

January 7, 2020

Compared to other states such as Colorado, Nevada, and Oregon, Ohio was lagging in the exploration of the opportunities presented by the lucrative hemp industry; however, after the approval of the 2014 Farm Bill, Ohio has now turned into a trendsetter in federally certified hemp programs.

Louisiana, New Jersey, and the Buckeye State submitted their hemp programs to the USDA, and on Dec. 27 the agency announced that it has approved their plans. The three states are the first in the U.S. to have their programs approved by federal hemp regulators.

The executive director of the Ohio Hemp Association trade group, Tomm Haren, said that it is a huge step for Ohio to be one of the three states to have an approved USDA plan even though it was late in joining the hemp sector. Haren Credits the Department of Agriculture in Ohio for enabling the approval process to take place sooner.

Kentucky was among the first states to embrace the hemp pilot program since the U.S. passed the 2014 farm bill. This led to the spread of industrial hemp, which steered the rise of the CBD market, whose legality was established after the 2018 Farm Bill was passed.

The 2018 Farm Bill removed hemp’s federal status as a Schedule 1 substance, which led to the development of federal rules and regulations vis-à-vis hemp and hemp derivatives. The removal of the controlled substance status legitimized the sale of CBD products and the formation of hemp programs in states that were previously prohibited.

However, this was not the case in Ohio because when the state created the rules for the Medical Marijuana Control Program back in 2016, the lawmakers categorized hemp as marijuana due to a lack of information on the differences and understanding of the two. Unlike marijuana, hemp does not induce a high in the users, and it is mostly used for CBD extraction. Hemp is also used to make other products such as clothing, roofing, and paper. Federal regulations require hemp crops to have a THC concentration of not more than 0.3%.

The approval of the 2018 Farm Bill created confusion in Ohio because the state law stipulated that CBD products were not to be sold outside the licensed marijuana dispensaries, yet previously, that was not the case as food stores could sell CBD products. The Cincinnati health department even raided one health food store and embargoed all its CBD products.

In July, Ohio Governor Mike DeWine signed Senate Bill 57 into law. The bill created a clear distinction between hemp and marijuana and brought the state’s hemp rules regarding hemp, especially the CBD products, in line with federal regulations.

The signing prompted the Department of Agriculture in Ohio to amp up their efforts in creating rules for a better hemp program, which included licensing of growers and testing of the hemp products. These rules would be submitted to the federal government as directed in the 2018 Farm Bill, whereby the USDA would then approve hemp programs submitted by states and Native American Tribes through their regulatory oversight program. On October 31, 2019, the USDA issued its Interim Final Rule and that paved way for states to start submitting their production programs.

Once the hemp program in Ohio is approved, farmers expect the ODA (Ohio Department of Agriculture) to start awarding cultivation and processing licenses in March, which would allow them to plant hemp this spring.

The hemp industry, including industry actors like No Borders Inc. (OTC: NBDR) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), is probably glad that matters are moving so well, so far, in Ohio.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$RIV $RIV.V $CNPOF How Entrepreneurs Can Benefit From Using CBD

January 7, 2020

Cannabidiol or CBD is a hemp extract that’s literally taking the world by storm. It is one of the over 100 cannabinoids produced by the cannabis plant, and it stands out from the pack due to its potent and versatile medicinal properties. People have been using the compound to manage a variety of conditions ranging from insomnia to chronic pain.

In June 2018, the FDA approved a CBD based drug to treat seizures in two rare forms of pediatric epilepsy, Lennox-Gastaut Syndrome and Gastaut Syndrome.

The chemical’s versatility has made it possible for people from all walks of life to use CBD products, from athletes looking for a little relief from pain and inflammation to the corporate employee under tremendous stress. Entrepreneurs too can jump onto the bandwagon, as CBD’s physical and mental benefits are wide-ranging, and they can be useful to someone involved in entrepreneurship. How so?

CBD can lower stress levels. CBD, and cannabis in general, are quite famous for their stress-relieving properties. The only difference is CBD doesn’t intoxicate you as marijuana would, and that makes it perfect for entrepreneurs. It’s a great way to keep stress levels down while maintaining laser-sharp focus. According to Penguin CBD, a few drops of CBD oil held under the tongue is all it takes to lower your stress levels.

CBD can improve sleep. Insomnia is a liability to an entrepreneur who has to be fresh and on point every day, and when it becomes chronic, it threatens your health. CBD has been found to improve sleep quality, without the side effects of pharmaceutical sleeping pills. You’ll be able to enjoy a restful sleep and wake up fresh and ready to tackle the day’s problems.

CBD is a great pain reliever. A large percentage of Americans who use CBD do so for pain relief. The chemical has anti-inflammatory properties that make it a potent pain reliever. We all know sitting for long hours in front of a computer isn’t good for your back or neck. Not to mention the migraines that might pop up once in a while due to overwork. CBD is an effective way to dull the pain, and it will help you focus more on what’s more important for the business.

CBD works great against anxiety and depression. According to a 2015 study, nearly half of entrepreneurs are dealing with at least one mental illness, and anxiety tops the list. Entrepreneurs have to navigate a complex business world, taking all the risks by themselves, and while it’s extremely rewarding when it pays off, the anxiety along the way makes it hard to keep pushing. CBD has been found to be quite effective against anxiety, and a lot of people are turning to the hemp extract instead of pharmaceuticals.

Analysts believe that CBD product manufacturers like Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Hemptown USA get a lot of satisfaction from the fact that their products have such a profound effect on various groups of people, such as entrepreneurs.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$JMDA CEO Details Big Payoff to Early Sacrifices

$SRAX BIGtoken Mobile App Allows Users to Unlock Value of Data

January 7, 2020

$LXRP Unfavorable Laws Force Hemp Businesses Out of Florida

January 6, 2020

Hemp is an extremely versatile crop, said to have thousands of uses. The plant’s uses range from industrial applications like making bioplastic and construction materials, to nutritional uses. Not to mention the plethora of cannabinoids it produces, such as cannabidiol (CBD) and cannabigerol (CBG), which have their own wide-ranging applications.

The 2018 Farm Bill released hemp from decades of illegality, classifying cannabis with less than 0.3% THC as industrial hemp. The legislation gave farmers the green light to grow the crop under state and tribal programs, as long as they adhered to the federal regulations.

Floridian Bryan Coco saw this as a chance to invest majorly in the crop, having started his hemp company called HGE, the year before. The market for hemp was bound to grow quickly, and he was determined to be right in the middle of all of it. The state’s nearly year-round sunshine and vast stretches of farmland made it an ideal location for hemp cultivation, and Coco was planning on relocating his company headquarters there.

Things, however, didn’t go as planned. Despite the state having the ideal conditions for farming hemp, the legislative process was almost impossible. At the time, the state had issued only one permit to the University of Florida and all other permits were delayed till early 2020. This eventually pushed Coco to Pennsylvania, which already had a hemp pilot program underway.

HGE is now thriving, he says, with a 120-acre farm and a 4,500 square foot indoor growing facility. “Pennsylvania has been diversifying its pilot program for years, which has put us in a better position to supply farmers with the compliant seed they now need,” he adds.

According to the Farm Bill, states were to establish their own hemp programs and submit them to the USDA for approval. They were allowed to launch the programs before the USDA gave its approval, but Florida’s pilot program is available only to universities. This is due to a bill signed by Governor Rick Scott in 2017.

Critics say that the move is stifling new business growth and will ultimately lead to a less healthy marketplace. Plenty of hemp businesses have been forced to ditch the state for regions with more progressive hemp regulations.

“The industry is footloose and moves to whatever state offers the most business-friendly environment. Onerous regulations can present significant costs, it’s not just taxes that can drive businesses elsewhere,” says Jonathan P. Caulkins, a drug policy expert, and professor at Carnegie Mellon University.

Industry watchers believe that the hemp industry, including VPR Brands LP (OTCQB: VPRB) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), could be very disappointed that the Sunshine State still has impediments preventing hemp producers from taking advantage of the ideal conditions to grow hemp.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$YGYI 7 Tips for Buying the Best CBD Online

January 6, 2020

Cannabidiol has been having a great run for the last couple of years. From near obscurity, the chemical has risen to amazing heights, with experts estimating the market for CBD to be worth $20 billion by 2026. In 2018, CBD gummies were the third most searched for food by Americans, proving just how beloved the hemp extract has become.

People have been using it to help manage a variety of ailments from chronic pain and insomnia, and even though there’s little scientific proof to back these claims, the anecdotal evidence paints it as a potent and versatile medicine.

Sadly, the budding industry is barely regulated, and sellers are free to enter as they please. This has resulted in an unregulated sector with thousands of products, some up to code, many of them not. As a consumer, you have to take steps to make sure the products you buy online are safe from consumption and actually contain CBD.  So how does one do it?

Go with trusted brands. Buying from a trusted brand is a simple way of making sure you get quality CBD. Still, a little discretion is advised. Don’t just go for big names as they tend to overprice their products. Newer brands could offer the same quality at more affordable prices.

Research cultivation practices. CBD is derived from hemp, which is known to absorb and store impurities from the soil. Hemp that’s grown organically without chemical pesticides, herbicides and fertilizers will produce unblemished, high-quality CBD.

Don’t forget to check third party lab tests. CBD products ought to be tested in a third-party lab to check for high THC levels and contaminants such as heavy metals. The results should be available online or upon request. If you cannot find any third-party lab test results for a product, chances are it is of low quality.

Read the ingredients list. This is great advice for any processed product. Make sure you check the list of ingredients before buying CBD products. This will keep you from buying a product with ingredients that compromise the CBD’s effectiveness.

Understanding the extraction process. CBD is extracted from hemp through a number of methods, each with different results. The CO2 process is the most effective, as it uses pressurized carbon dioxide to pull the CBD and compress it into a cold liquid state. If the extraction is done correctly, the extract will maintain all of its rich properties.

Check the dosage. Make sure you understand how much CBD is in each dose you purchase, and how much CBD works comfortably for you. This will help you tailor your search to products that suit you and your dosing needs, and you’ll be able to avoid unwanted problems like side effects.

Understand the pricing. This might take you some time, but understanding the pricing is crucial before making a purchase. Cheaper products tend to be lower in quality, and super expensive ones will just rip you off. Quality CBD products average $0.11 to $0.22 per milligram, so make sure you stick within this range. Any more or less and you won’t be getting value for your money.

If you consider all the factors above when making a purchase decision, you will increase your chances of selecting the best product at the right price. Giving customers such vital information may be the reason why CBD companies like Youngevity International Inc. (NASDAQ: YGYI) and Neutra Corp. (OTC: NTRR) invest a lot in enabling consumers out make informed decisions about cannabidiol products.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$GNPX to Present at Biotech Showcase 2020 in San Francisco

$SGLB Disruptive In-Process, QA Software for Commercial 3D Metal-Printing

• SGLB president and CEO discusses disruptive 3D metal-printing technology and how it will reconfigure factory operation
• 3D metal printing is recognized as disruptive technology that can enhance numerous industries, including defense operations and capabilities
• Sigma Labs is set to harness benefits of focused efforts from 2019 in the upcoming year
• 3D metal printing is a multibillion-dollar market

Sigma Labs Inc. (NASDAQ: SGLB) President and CEO John Rice recently joined NNW’s Stuart Smith to discuss the company’s disruptive technology (http://nnw.fm/2DNrE). A leading developer of quality-control software for the commercial 3D-printing industry, SGLB offers PrintRite3D® software: a proprietary, real-time, computer-aided inspection (CAI) technology. The product is unique as the only in-process, quality-assurance software that revolutionizes the commercial 3D metal-printing industry by enabling nondestructive quality control intervention during the production process.

Sigma Labs was founded in 2010 by a team of senior scientists and engineers from Los Alamos Labs who were poised to develop revolutionary parts in metallurgy science. Managed by experts from different science disciplines such as physics, metallurgy, mechanical engineering, optics, artificial intelligence and data science, the company has…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$SRAX CCPA is Effective and Most Companies Are Not Compliant

BIGtoken Provides New Path to Ad Targeting With Opt-In Data

LOS ANGELES, Jan. 6, 2020 — SRAX, Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, offers a California Consumer Privacy Act (CCPA) compliant data set. CCPA became effective on January 1, 2020, and according to major news sources most companies are not yet compliant or prepared for the impact CCPA will have.

The use of third-party data is threatened by the CCPA as it will greatly affect what data can be used for targeting purposes. This means first-party data still reigns supreme and for brands, managing customer relationships is more important now than ever before.

SRAX’s BIGtoken is a platform that enables people to own and earn from their data. With more than 16 million users worldwide, BIGtoken is a CCPA compliant data set, which is very valuable when third-party data sets are in question. The platform offers informed opted-in consumer data from survey responses, connections to consumers’ online accounts, and touchpoints across their consumer journeys.

“This is a crucial time for all businesses, not just in California, but worldwide,” says Kristoffer Nelson, COO of SRAX and co-founder of BIGtoken. “California is one of the first states to implement data protection laws in the United States, but many other states are already following suit. As the nation and the rest of the world progresses to more stringent privacy laws, BIGtoken is well-positioned to provide targeting and measurement methodologies to brands when other data sets and services are in question.”

About SRAX
SRAX, Inc. (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.srax.com.

About BIGtoken
BIGtoken, built by SRAX (NASDAQ: SRAX), is a consumer data management and distribution system. BIG is the first consumer-managed data marketplace where people can own and earn from their data. Through a transparent platform and consumer reward system, BIG offers consumers choice, transparency, and compensation for their data. Participating consumers earn rewards, and developers are able to build pro-consumer online experiences on top of the BIG platform. The system also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. For more information on BIGtoken, visit www.bigtoken.com.

CONTACTS:

Kirsten Chapman
LHA Investor Relations
415-433-3777
srax@lhai.com

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$POAI Announces Appointment of Pam Prior to its Board of Directors

$TGODF Cincinnati Nurse Debuts CBD Product Line

January 2, 2020

At the moment, interest in hemp-derived cannabidiol (CBD) is at an all-time high. Ever since the 2018 Farm Bill legalized hemp and by extension CBD, the market for products infused with CBD has been steadily rising. Experts estimate that the industry will be worth at least $20 billion by 2026.

However, the sector has been plagued by one issue: quality control. As many have put it, the hemp/CBD industry rapidly outpaced regulatory authorities, resulting in a market filled with substandard and contaminated products.

A nurse is Cincinnati is looking to change that. Jeri Schulz, a registered nurse, launched her company online, and it will sell a variety of high-quality hemp-based CBD products. Dubbed ‘Tulip Tree’, the West Chester-based company will sell tinctures, gummies and pet treats. According to Schulz, it will focus on providing prescription-free alternatives for health and wellness.

Pharmaceuticals are notorious for their side effects, some of them quite extreme. CBD, on the other hand, doesn’t have side effects, although high amounts of CBD have been found to affect the liver. Although there’s little scientific research to back the claims, users have said CBD offers relief from a variety of ailments including chronic pain and anxiety.

Epidiolex, a CBD-based drug, is the only instance a medical claim has been properly researched and validated. The U.S. Food and Drug Administration (FDA) approved the drug to treat two rare pediatric epilepsies, Lennox-Gastaut Syndrome and Dravet Syndrome.

Schulz is working with a Colorado-based CBD supplier and a Florida packaging firm. She has experience in hospice, critical care, cardiology, and natural medicine, and she says that she envisions Tulip Tree as a resource for nurses and other health care professionals interested in self-care. She also wants guidance for patients on the safe and effective use of CBD products, custom dosing, and understanding potential drug interactions.

“I want to market to the health care community. The nursing profession is a mentally, emotionally and physically demanding job. These people have a passion for this, but nurses are burning out because it’s such a stressful job.”

Prices for their products start at $14.95 for CBD gummies, and the high-end stuff costs $65.95. The company also has some products for pets. The Fur Baby Balance Premium Pet Phytos Dog Chews costs $35.95 for 30 beef-flavored chews with 2 mg of CBD.

The company extracts all of the THC (delta-9 tetrahydrocannabinol) from the hemp during processing. All the finished products go through third-party lab testing to make sure they are devoid of solvents, heavy metals, and pesticides.

“I think my products stand out. There are only a handful of companies out there that have premium products. It’s a little more expensive as a product because of the extra filtration to remove the THC. It was important to me because my marketing is going to nursing and health care professionals. They don’t want anything that might have THC in it because they were afraid of being tested THC positive,” she says.

CBD sector players like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) could be happy that medical professionals like Shulz are joining the cannabidiol industry since this will help to avail more trustworthy sources of information about CBD.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

$SRAX Offers Consumers Power to Own Their Data

$RIV $RIV.TO $CNPOF 5 Problems Farmers Identify in the USDA Hemp Rules

January 3, 2020

The 2018 Farm Bill was instrumental in pushing the hemp industry from restriction to one worth billions of dollars. The legislation legalized the cultivation and sale of industrial hemp, classifying hemp as cannabis with less than 0.3% THC content. On condition that farmers grew the crop under state and tribal programs, and they adhered to the rule on THC (delta-9 tetrahydrocannabinol), they were free to farm hemp.

A few months later, there was a raving hemp Industry, but since there were hardly any regulations, players in the sector, especially farmers, were denied essential services like insurance and banking. In October, the U.S. Department of Agriculture finally released its much-awaited interim final rule on hemp, with a comment period for interested parties to offer their opinions on the interim rule. Here are five issues that seem to cut across the board;

Total THC vs. delta-9. The Farm Bill outlawed only delta-9 THC, but the new rule proposed testing for the entire THC spectrum. According to Dustin Coleman from Michigan, eliminating the delta-9 test will destroy the entire hemp industry as it is now, and it will prevent farmers from taking the risk in future.

“As a current hemp farmer following all rules and regulations carefully, I feel this is an intentional slap in the face of the small farmers who risked it all, just for our government to introduce rules that cannot possibly be followed.”

Sampling window and DEA labs. Elizabeth Meler from North Carolina argues that there is not enough manpower within the USDA, along with an overall lack of DEA registered testing sites that can accommodate the number of tests that will need to be done. She says that there is no way this can be done in a timely fashion to allow a farmer to get the tests done on all varieties they are growing, receive the test results and harvest within the 15-day sampling window.

Unstable Genetics. According to William Becker from West Virginia, the number of regulations on hemp is becoming unrealistic when no one has grown the crop for generations. He argues that until the genetics are more thoroughly established, the USDA should loosen the regulations to allow American farmers to have greater chances of success.

Hot hemp is the term coined for hemp with more than the federally allowed THC levels. Kurt Beckley from Washington State says that forcing farmers to destroy their crops is a devastating consequence for the already vulnerable demographic, especially given that there are no options to remediate the hot hemp.

He adds that since hot hemp doesn’t qualify for farm insurance, destroying the failed crop could render a farmer bankrupt within a single year. He suggests that mechanisms be instituted to remediate hot hemp so that it can still be sold.

THC Testing itself has been an issue. According to Virginia-based Susan Corbett, farmers cannot predict exactly how different cultivars will react in different environments, soils, and climates. Restricting the growth to 0.3% THC will severely hurt the market, she says.

“We believe the limit should be 1% THC. This will allow farmers to produce high-quality CBD flowers that will bring a decent profit while maintaining a non-psychoactive outcome.”

Analysts are of the view that the entire hemp industry, including companies like Green Hygienics Holdings Inc. (OTCQB: GRYN) and Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), are waiting to see how the USDA responds to the concerns above.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

$JMDA CEO Details 2019 Successes and Forward Strategy in Weekly Update

$PBIO Zacks Maintains Strong $4.44 Price Target

• Zacks has reiterated support for their initial $4.44 share price target for Pressure BioSciences
• PBIO’s fundamentals remain strong, with record sales of consumables and increased revenue from products and services over same quarter previous year
• Company anticipates doubling of total revenue in 2020, driven by anticipated sales of their proprietary BaroShear K45 System, which provides the CBD market with much-needed, superior water-soluble nanoemulsions of CBD Oil

Zacks Small Cap Research, a division of Zacks Investment Research, has announced that they are maintaining their strong $4.44 share price target originally stated in their initial coverage of Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the sale and development of pressure-based consumables, instruments, and platform technology solutions to the global life sciences industry. PBIO’S unique and enabling pressure platform technologies can be used in many large and growing markets (e.g., food preservation, medical/lab applications, and, importantly, CBD oil water solubility).

The Zacks report (http://nnw.fm/4RMgj) points to demand that “is expected to accelerate starting in 2020,” which nonetheless follows many years of consistent yearly revenue increases by PBIO. The company itself is standing by its stated anticipation of doubling revenue in 2020, due to expected sales of their…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$YGYI Set to Ring Nasdaq Closing Bell on January 7 in Celebration of Fit Week 2020